10:27:35 Europe / Stockholm
2024-03-20 08:53:12

With a sharp focus on expanding its market to regenerative medicine, medtech company PHI has a growth trajectory that is on a notable upward trend, marked by its highest-ever sales performances in the last quarter. BioStock talked to the company CEO, Patrik Eschricht, for an operational overview and to learn about the behind-the-scenes developments right now.

Read the full interview with Patrik Eschricht at biostock.se:

https://www.biostock.se/en/2024/03/shift-to-regenerative-medicine-increases-growth-prospects-for-phi/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/